PTC Therapeutics | PTCT - Capitaux Propres Et Réserves

Prix De L'Action
65.28
Variation Quotidienne
0.22 0.34%
Mensuellement
-3.67%
Annuel
30.69%
Q2 Prévisions
66.77




Capitaux Propres Et Réserves Changement Date
Acadia Pharmaceuticals USD 917.27M 94.89M 2025-09
Alnylam Pharmaceuticals USD 1.08B 286.2M 2026-03
Amgen USD 9.19B 532M 2026-03
BioCryst Pharmaceuticals USD -119.15M 268.74M 2025-12
Biogen USD 18.65B 394.9M 2026-03
BioMarin Pharmaceutical USD 6.09B 30.29M 2025-12
Cytokinetics USD -659.62M 138.5M 2025-12
Daiichi Sankyo JPY 1.71T 57.86B 2025-12
Enanta Pharmaceuticals USD 126.59M 61.87M 2025-12
Esperion Therapeutics USD -301.96M 149.4M 2025-12
Gilead Sciences USD 22.62B 1.16B 2025-12
Incyte USD 5.62B 455.37M 2026-03
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
Ironwood Pharmaceuticals USD -264.16M 44M 2025-09
Karyopharm Therapeutics USD -292.93M 23.67M 2025-12
Novartis USD 46.13B 1.38B 2025-12
Pfizer USD 92.8B 4.11B 2025-09
PTC Therapeutics USD -205.31M 49.56M 2025-12
Puma Biotechnology USD 115.27M 10.55M 2025-09
Roche Holding CHF 33.8B 758M 2025-12
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Sarepta Therapeutics USD 1.14B 179.5M 2025-12
TG Therapeutics USD 648.02M 40.8M 2025-12
Ultragenyx Pharmaceutical USD 9.16M 142.13M 2025-09
Vertex Pharmaceuticals USD 18.67B 1.35B 2025-12
Xencor USD 635.59M 10.27M 2025-12